Medicines for Malaria Venture is a not-for-profit public-private partnership that was established as a foundation in Switzerland in 1999. From Wikipedia
Novartis will roll out the cherry-flavored, dissolvable therapy largely at cost after Ghana’s authorization with approvals expected from eight other African regulators within 90 days.
